This invention provides 5-HT1F agonists of Formula (I) where A-B, X, and R are as defined in the specification. The invention also encompasses pharmaceutical formulations employing the compounds of the invention as well as methods of treating conditions associated with 5-HT1F activation employing these compounds or compositions.
申请公布号
WO9925348(A1)
申请公布日期
1999.05.27
申请号
WO1998US24256
申请日期
1998.11.13
申请人
ELI LILLY AND COMPANY;FILLA, SANDRA, ANN;MATHES, BRIAN, MICHAEL;SCHAUS, JOHN, MEHNERT
